Literature DB >> 32335011

Rhipicephalus microplus serpins interfere with host immune responses by specifically modulating mast cells and lymphocytes.

Mariana L Coutinho1, Bruna Bizzarro2, Lucas Tirloni3, Markus Berger4, Carlo Jose Freire Oliveira5, Anderson Sá-Nunes6, Itabajara Silva Vaz7.   

Abstract

Rhipicephalus microplus ticks feed on a bovine host for three weeks. At the attachment site, inflammatory and immune responses are triggered resulting in the recruitment of cells and production of a set of immunological mediators. To oppose the host's immune responses, ticks inoculate bioactive salivary molecules capable of interfering with these defense mechanisms. Serpins are among the most frequent molecules present in tick saliva and have been shown to negatively affect the host's anti-tick immunity. R. microplus has at least eighteen full-length serpins (RmS) and eleven are transcribed during blood feeding. Among them, RmS-3, RmS-6, and RmS-17 are present in the saliva of engorged females. Here, the effect of these serpins on the immune responses was evaluated in cells involved in innate/inflammatory (mast cells and macrophages) and adaptive (T cells) immunity. RmS-3 modulated mast cells due to its inhibitory activity on peritoneal rat chymase and on vascular permeability in acute inflammation. In addition, both RmS-6 and RmS-17 inhibited vascular permeability. Of the three serpins studied, neither affected activation nor inflammatory cytokine production by murine macrophages. On the other hand, RmS-3 and RmS-17 presented an inhibitory effect on the metabolic activity of lymphocytes, with the latter being the most potent, while RmS-6 had no effect on it. This activity was associated with a decrease in lymphocyte proliferation, but not with induction of cell death. The present study highlights the powerful modulatory role of tick salivary serpins in the host's immune system and inspire the discovery of targets for the treatment of inflammatory/immune disorders.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Immunomodulation; Lymphocytes; Mast Cells; Serpins; saliva

Year:  2020        PMID: 32335011     DOI: 10.1016/j.ttbdis.2020.101425

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  5 in total

Review 1.  Host Immune Responses to Salivary Components - A Critical Facet of Tick-Host Interactions.

Authors:  Abid Ali; Ismail Zeb; Abdulaziz Alouffi; Hafsa Zahid; Mashal M Almutairi; Fahdah Ayed Alshammari; Mohammed Alrouji; Carlos Termignoni; Itabajara da Silva Vaz; Tetsuya Tanaka
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

Review 2.  Serpins in Tick Physiology and Tick-Host Interaction.

Authors:  Muhammad Nadeem Abbas; Adéla Chlastáková; Mohamed Amine Jmel; Evangelia Iliaki-Giannakoudaki; Jindřich Chmelař; Michail Kotsyfakis
Journal:  Front Cell Infect Microbiol       Date:  2022-05-19       Impact factor: 6.073

Review 3.  Tick Salivary Compounds for Targeted Immunomodulatory Therapy.

Authors:  Hajer Aounallah; Chaima Bensaoud; Youmna M'ghirbi; Fernanda Faria; Jindr Ich Chmelar; Michail Kotsyfakis
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

4.  Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression.

Authors:  Yamato Sajiki; Satoru Konnai; Yoshinori Ikenaka; Kevin Christian Montecillo Gulay; Atsushi Kobayashi; Luís Fernando Parizi; Benvindo Capela João; Kei Watari; Sotaro Fujisawa; Tomohiro Okagawa; Naoya Maekawa; Carlos Logullo; Itabajara da Silva Vaz; Shiro Murata; Kazuhiko Ohashi
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

5.  Iripin-3, a New Salivary Protein Isolated From Ixodes ricinus Ticks, Displays Immunomodulatory and Anti-Hemostatic Properties In Vitro.

Authors:  Adéla Chlastáková; Jan Kotál; Zuzana Beránková; Barbora Kaščáková; Larissa Almeida Martins; Helena Langhansová; Tatyana Prudnikova; Monika Ederová; Ivana Kutá Smatanová; Michail Kotsyfakis; Jindřich Chmelař
Journal:  Front Immunol       Date:  2021-03-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.